<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Immunomedics, Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Immunomedics, Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Immunomedics_Inc-1008485</link>
<lastBuildDate>Saturday, August 30, 2008 10:01:51 AM</lastBuildDate>
<alacra:xlsid>1008485</alacra:xlsid>
<alacra:company>Immunomedics, Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PZM-0001-27742890</link><guid isPermaLink="false">newstex/PZM-0001-27742890</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Aug. ##, #### (GlobeNewswire delivered by Newstex) -- MORRIS PLAINS, N.J., Aug. ##, #### (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07001004</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002008</newstex:cat><pubDate>8/29/2008 10:03:50 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18022000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:Publication><title>Immunomedics Announces Fiscal 2008 Results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PZM-0001-27742890</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">IMMUNOMEDICS INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">GERARD G GORMAN</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">IMMU</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PZM-0001-26639813</link><guid isPermaLink="false">newstex/PZM-0001-26639813</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> MORRIS PLAINS, N.J., Jul. ##, #### (July delivered by Newstex) -- Immunomedics, Inc. (Nasdaq:IMMU) and Nycomed GmbH ("Nycomed") announced today that they have entered into a license and collaboration agreement providing Nycomed a worldwide...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">15000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">15031000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07001004</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>7/14/2008 9:21:14 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18022000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PrimeNewswire</newstex:Publication><title>Immunomedics Announces Worldwide License and Collaboration Agreement With Nycomed for Veltuzumab for Non-Cancer Indications</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PZM-0001-26639813</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">IMMUNOMEDICS INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">IMMU</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/22915</link><guid isPermaLink="false">srp/22915</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:### American Road, Morris Plains, New Jersey ##### Incorporated:DelawareWeb Site: www.immunomedics.comSIC Classification: In Vitro and In Vivo Diagnostic Substances (####) Business Description: Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. Indices:Russell ####, Russell #### ...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">22915</srp:company><title>Immunomedics, Inc.</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">452907108</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">IMMU</srp:ticker><pubDate>10/6/2006 12:16:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">22915</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>